ATE449162T1 - Herstellung von tcr gamma delta t-zellen - Google Patents

Herstellung von tcr gamma delta t-zellen

Info

Publication number
ATE449162T1
ATE449162T1 AT01921047T AT01921047T ATE449162T1 AT E449162 T1 ATE449162 T1 AT E449162T1 AT 01921047 T AT01921047 T AT 01921047T AT 01921047 T AT01921047 T AT 01921047T AT E449162 T1 ATE449162 T1 AT E449162T1
Authority
AT
Austria
Prior art keywords
cells
gamma delta
tcr gamma
production
growth factors
Prior art date
Application number
AT01921047T
Other languages
English (en)
Inventor
David Bell
Danna Skea
Original Assignee
Therapure Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapure Biopharma Inc filed Critical Therapure Biopharma Inc
Application granted granted Critical
Publication of ATE449162T1 publication Critical patent/ATE449162T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01921047T 2000-04-03 2001-04-03 Herstellung von tcr gamma delta t-zellen ATE449162T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19403300P 2000-04-03 2000-04-03
PCT/CA2001/000444 WO2001075072A2 (en) 2000-04-03 2001-04-03 PRODUCTION OF TcR GAMMA DELTA T CELLS

Publications (1)

Publication Number Publication Date
ATE449162T1 true ATE449162T1 (de) 2009-12-15

Family

ID=22716029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01921047T ATE449162T1 (de) 2000-04-03 2001-04-03 Herstellung von tcr gamma delta t-zellen

Country Status (9)

Country Link
EP (1) EP1268746B1 (de)
JP (1) JP4982645B2 (de)
AT (1) ATE449162T1 (de)
AU (2) AU2001248162B2 (de)
CA (1) CA2405050C (de)
DE (1) DE60140526D1 (de)
ES (1) ES2336302T3 (de)
NZ (1) NZ522337A (de)
WO (1) WO2001075072A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101313061B (zh) 2005-11-18 2013-05-15 大学健康网络 扩增双阴性t细胞的方法
CA2659697A1 (en) 2006-08-01 2008-02-07 Arigen Pharmaceuticals, Inc. Method of proliferating lak cell
GB201506423D0 (en) 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
CN107075480A (zh) * 2014-07-09 2017-08-18 Tc生物制药有限公司 γδT细胞及其用途
GB201507368D0 (en) 2015-04-30 2015-06-17 Ucl Business Plc Cell
AU2016274633B2 (en) * 2015-06-09 2022-04-21 Gammadelta Therapeutics Ltd Methods for the production of TCR gamma delta+ T cells
DK3307875T3 (da) 2015-06-09 2022-03-21 Lymphact Lymphocyte Activation Tech S A Fremgangsmåder til fremstilling af tcr-gamma-delta+-t-celler
JP6621171B2 (ja) * 2015-06-22 2019-12-18 国立大学法人広島大学 Ｔ細胞活性化剤、ｔ細胞の活性化方法、および、ｔ細胞培養用培地
TW202020145A (zh) 2018-07-13 2020-06-01 國立大學法人京都大學 γδＴ細胞的製造方法
CA3162755A1 (en) 2019-11-25 2021-06-03 Kyoto University T-cell master cell bank
WO2023069322A1 (en) * 2021-10-20 2023-04-27 University Of Pittsburgh – Of The Commonwealth System Of Higher Education Methods and materials for expanding tumor infiltrating gamma-delta t cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2278847A1 (en) * 1997-01-31 1998-08-06 Hemosol Inc. Method for the production of selected lymphocytes
JPH10295368A (ja) * 1997-04-22 1998-11-10 Hitachi Chem Co Ltd ガンマー・デルタｔ細胞の製造法及び免疫治療剤
WO1999046365A1 (en) * 1998-03-12 1999-09-16 Emory University Methods and compositions for the selective expansion of gamma/delta t-cells
ATE421573T1 (de) * 1998-11-04 2009-02-15 Therapure Biopharma Inc Verfahren zur herstellung von gamma delta t zellen

Also Published As

Publication number Publication date
EP1268746A2 (de) 2003-01-02
WO2001075072A3 (en) 2002-04-25
AU4816201A (en) 2001-10-15
NZ522337A (en) 2004-12-24
ES2336302T3 (es) 2010-04-12
CA2405050A1 (en) 2001-10-11
EP1268746B1 (de) 2009-11-18
JP2003529363A (ja) 2003-10-07
JP4982645B2 (ja) 2012-07-25
AU2001248162B2 (en) 2007-02-01
DE60140526D1 (de) 2009-12-31
WO2001075072A2 (en) 2001-10-11
CA2405050C (en) 2010-06-15

Similar Documents

Publication Publication Date Title
DE60323468D1 (de) Vögelzell-linien und deren verwendung zur herstellung interessanter biologischer substanzen
HUP0105052A2 (hu) Eljárások nukleinsav amplifikálására és szekvenálására
CA2058930A1 (en) Media for cell growth and method for making them
DE69939947D1 (de) Verfahren zur herstellung von polypeptiden in mutierten aspergillus zellen
ES2120946T3 (es) Sistemas y medios de cultivo celular.
WO2003089567A3 (en) Apparatus and method for a cell culture in a bioreactor at high cell concentration
AR000921A1 (es) Composicion como medio de cultivo para soportar el crecimiento de poblaciones celulares. metodo in vitro para sostener el crecimiento in vitro dede celulas eucarioticas, respectivamente para in vitro incrementar las propiedades del tejido submucoso para cultivar celulas islote o analizar in
ATE449162T1 (de) Herstellung von tcr gamma delta t-zellen
AU4017501A (en) Cell culture spinner flasks
DE69735059D1 (de) Erhöhte produktion von taxanen durch zellkulturen von taxus-arten
ATE421573T1 (de) Verfahren zur herstellung von gamma delta t zellen
DK1292672T3 (da) Immobiliseringsbærer omfattende et poröst medium
TR200001960T2 (tr) Biyolojik ürünlerin üretimi için hücrelerin hazırlanması.
DE50013563D1 (de) Verwendung von pankreatischer Procarboxypeptidase B zur Herstellung von Insulin
RU2009149159A (ru) Способы предотвращения глюконилирования белков
ATE469209T1 (de) Herstellung und verwendung von basalmembranpartikeln
DK0651788T3 (da) Fremgangsmåde til dyrkning af en celletype i en cokulturfremgangsmåde med leverceller
DE50202362D1 (de) Verfahren zur Erhöhung der Wachstumsrate von Zellen in statischen Flüssigmedien
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
DE69014723D1 (de) Zellzüchtungsverfahren.
KR830001367A (ko) 열에 안정한 글루코아밀라제의 제법
KR910012253A (ko) 폴리-3-히드록시부티르산의 생합성 방법
KR910001053A (ko) 형질전환된 효모를 이용하여 외래 단백질을 고농도로 생산하는 방법
SU1692145A1 (ru) Способ получения клеточной культуры
KR960006940A (ko) 동물세포 배양법을 이용한 뉴캣슬병 백신의 생산방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties